Absci Corporation (ABSI) vs Avalyn Pharma Inc. (AVLN)
- Absci Corporation ABSI 7.58 +1.34%
- Avalyn Pharma Inc. AVLN 27.88 −6.32%
Absci Corporation and Avalyn Pharma Inc. are both Biotechnology companies. Absci Corporation and Avalyn Pharma Inc. are of similar size ($1.3B and $1.2B). Avalyn Pharma Inc. has the higher net margin (0.00% vs −8,451.3%) and the higher return on invested capital (−127.6% vs −182.0%). Across the 11 metrics below, Avalyn Pharma Inc. leads on 9 and Absci Corporation on 2.
Valuation
Profitability
| Metric | ABSI | AVLN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (8,812.31%) | 0.00% | 0.00% |
| Net margin | (8,451.31%) | 0.00% | 0.00% |
| Free cash flow margin | (7,550.91%) | 0.00% | 0.00% |
| Return on equity | (58.59%) | 0.00% | (50.72%) |
| Return on assets | (51.87%) | 0.00% | (45.56%) |
| Return on invested capital | (181.96%) | (127.60%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack